Pennant Investors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-168,100	Closed	-$291K	–	24
2024 Q2	$291K	Hold	168,100	–	–	0.08%	31
2024 Q1	$402K	Hold	168,100	–	–	0.1%	28
2023 Q4	$560K	Buy	+168,100	New	+$560K	0.12%	13